Previous Page  18 / 28 Next Page
Information
Show Menu
Previous Page 18 / 28 Next Page
Page Background

Page 61

allied

academies

Cell Science, Stem Cell Research &

Pharmacological Regenerative Medicine

November 29-30, 2017 | Atlanta, USA

Annual Congress on

Adv cel sci tissue cul 2017 | Volume 1 Issue 2

Purpose:

Explore the feasibility of differentiating skin stem

cells into corneal endothelial cell-like cells (CEC-like cells) to

cure corneal endothelial dysfunction.

Methods:

Human skin stem cells were cocultured with

corneal endothelial cells (CECs) through transwell coculture

system to obtain CEC-like cells. CEC-like cells were identified

by immunofluorescence, real time RT-PCR, western blotting.

Dil-labeled CEC-like cells were transplanted into the rabbit’s

corneal endothelial dysfunction models to detect the cell

function

in vivo

. Histological examination of corneas was

performed to detect CEC-like cells attachment.

Results:

CEC-like cells could be derived from skin stem

cells and they had similar morphology and characteristic

to CECs. They expressed major markers of CECs, such as

Na+/K+ ATPase alpha 1, zonula occludens-1 and other

functional markers. The expression levels of differentiation

transcription factors FoxC1 and Pitx2 were also significantly

upregulated compared with skin stem cells. CEC-like cells

were transplanted into the rabbit’s corneal endothelial

dysfunction models, their corneal transparency and the

thickness recovered while the control groups remain opaque.

Histological examination showed Dil-labed CEC-like cells

covered nearly full Descemet’s membrane and expressed

Na+/K+ ATPase in CEC-like cells injected group while almost

no cells were detected on Descemet’s membranes in control

group.

Conclusions:

This protocol enables efficient production of

CEC-like cells fromskin stemcells and these CEC-like cells have

therapeutic effect in corneal endothelial dysfunction model.

The renewable cell source and novel deriving method may

lead to potential applications in cell replacement therapy for

corneal endothelial dysfunction.

e:

xywu8868@163.com

Alternative therapy of corneal endothelial dysfunction using skin-derived precursors

Xinyi Wu

and

Lin Shen

Qilu Hospital of Shandong University, China